Levetranol 500mg Tablet contains Levetiracetam, an antiepileptic medication indicated for the treatment of partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, thereby reducing neuronal excitability and seizure activity. The 500mg dosage provides an effective therapeutic option for adults and adolescents aged 16 years and older. Levetranol is typically administered orally, with dosing individualized based on clinical response and tolerability. It is well tolerated, with common adverse effects including somnolence, dizziness, headache, and fatigue; however, serious neuropsychiatric reactions such as mood changes, irritability, or depression may occur and warrant close monitoring. Renal function should be assessed prior to initiation and periodically during treatment, as dose adjustments are necessary in patients with impaired renal clearance. Levetranol should be used cautiously in patients with a history of psychiatric disorders. It is not recommended during pregnancy unless the potential benefit outweighs the risk. Concomitant use with other antiepileptic drugs is common and generally safe, but clinicians should monitor for potential drug interactions or additive side effects.